Deals, Partnering

Abbott accelerates emerging markets pharmaceutical leadership with Zydus Cadila collaboration

Posted on 11 May 2010


Licensing and supply agreement with Zydus Cadila of India for a portfolio of pharmaceutical products that Abbott will commercialize in 15 emerging markets, enabling the company to further accelerate its emerging markets growth. Abbott will gain rights to at least 24 Zydus products in 15 key emerging markets where Abbott has a strong and growing presence. The agreement also includes an option for the addition of more than 40 Zydus products to the collaboration.

Print Friendly, PDF & Email

Leave a Reply